Hayden Michael R
SEC Form 4 insider trading activity
Hayden Michael R has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including ABCL, IONS, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, Hayden Michael R is listed as Director at AbCellera Biologics Inc. Inside the rolling window, Hayden Michael R reported 4 open-market purchases totaling $2.1M in ABCL and IONS and no open-market sales. The largest disclosed transaction in the window is a purchase of 15,000 IONS shares on Jul 30, 2026, worth $801K.
Companies traded
Other insiders at ABCL
Insider Buying
$2.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hayden Michael R made?
Hayden Michael R has filed 4 SEC Form 4 filings (5 transaction rows) across 2 companies, including ABCL, IONS since 2026.
Which companies does Hayden Michael R trade?
Hayden Michael R has filed SEC Form 4 disclosures for 2 companies, including ABCL, IONS.
When was Hayden Michael R's most recent SEC Form 4 filing?
Hayden Michael R's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is Hayden Michael R's total buy and sell value in the current window?
Inside the rolling retention window, Hayden Michael R bought $2.1M and sold $0 based on SEC Form 4 filings.
What was Hayden Michael R's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 15,000 IONS shares on 2026-07-30, worth $801K, per SEC Form 4 filings.